Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

Myovant Sciences Shares Rise on NDA Filing for Uterine Fibroid Combination Therapy Drug

Shares of Myovant Sciences traded 40% higher after the company reported that it has submitted a New Drug Application to the FDA for once-daily relugolix combination tablet for the treatment of women with uterine fibroids. Healthcare company Myovant Sciences Ltd. (...
Streetwise Reports | June 2, 2020 |

This Signal Points To More Upside In Stocks

NEW MONTHLY SIGNALS The MSCI World Index tracks over one thousand large and mid-cap stocks in twenty-two developed countries, covering 85% of the market capitalization in those regions. As shown via the chart below, a positive monthly MACD cross was just nailed down on the...
Chris Ciovacco | December 3, 2019 |

NASDAQ Listing & $100M Sales Guidance Fuels Peak’s H2/21

eResearch is pleased to publish an update Equity Research Report on Peak Fintech Group (PKK) ( CSE.PKK , OTC: PKKFF , Forum ) pertaining to the recent release of its revenue & EBITDA guidance. We are maintaining our Speculative Buy rating and increasing our one-year pr...
Featured Submission | August 3, 2021 |

The Next Catalyst for Gold

The precious metals sector remains in a correction, and as long as the 200-day moving averages hold, a bullish consolidation that began last September. Sure, Gold made a new high and is still holding around the previous high, but the rest of the sector has not confirmed th...
Jordan Roy-Byrne, CMT | January 23, 2020 |

Sustainable, Profitable Mineral Development for Today…and Tomorrow

(Click image to play video) Environmental sustainability while maintaining profitability and shareholder value are the hallmarks of any modern, forward-thinking company. This is especially the case in the critical minerals space. Avalon Advanced Materials Inc...
Dave Jackson | January 27, 2021 |

Drone Delivery Canada Opens Operations Center

Last week, Drone Delivery Canada Corp. (FLT:TSX.V; TAKOF:OTCQB) (DDC), announced the completion of a high-tech Commercial Operations Center (COC), in Vaughan, Ontario. The COC is open and ready for business. This is a very important milestone for DDC. The state...
Streetwise Reports | September 16, 2019 |

Buzz on the Bullboards: Hot Sector Favorites

One of the highlights of the Stockhouse Bullboards is that all companies are fair game. In our review of the weekly top 6 most viewed companies by sector, newcomers might expect big household names to dominate the charts. Instead, they find that Stockhouse investors are clued ...
Omri Wallach | September 11, 2019 |

Marinus Pharma Shares Open Up 41% on Phase 2 Epilepsy Trial Results

Marinus Pharmaceuticals reported positive top-line results for ganaxolone in its Phase 2 refractory status epilepticus trial with all patients achieving the primary endpoint. This morning Marinus Pharmaceuticals Inc. (MRNS:NASDAQ) , a pharmaceutical firm dedicated to...
Streetwise Reports | September 27, 2019 |

Gold, the Ultimate Safe Haven Asset. A Looming Nobel Prize?

Yesterday, the Nobel prizes in economics were awarded. Unfortunately, gold has been omitted and got nothing. How unfair! But looking at the Dutch central bank press release, gold would have much higher chances if they were the ones granting the prizes and not the Swedish ...
Arkadiusz Sieron | October 16, 2019 |

Cerecor Shares Rise 13% on Sale of Pediatric Portfolio for $32 Million

Shares of Cerecor Inc. are trading higher today after reporting that it will sell its pediatric portfolio to Aytu BioScience for $32 million in a combination cash and stock deal. Biopharmaceutical company Cerecor Inc. (CERC:NASDAQ) , which focuses on development and ...
Streetwise Reports | October 16, 2019 |
1 2 3 4 5 6 7 8 9